Item 7.01. Regulation FD.

Protagenic Therapeutics, Inc., a Delaware corporation (the "Company") has updated its corporate presentation (the "Corporate Presentation") that will be available in the "Investor Presentation" section of the Company's website at www.protagenic.com and will be used at investor and other meetings. A copy of the Corporate Presentation is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit
  No.            Description

99.1        Corporate Presentation




2

© Edgar Online, source Glimpses